Thus, although molecules involved in exacerbated inflammation and coagulation like inflammatory cytokines (i.e., IL6, IL1, TNFα) have shown a good prognostic value for sepsis progression and severity, targets to regulate inflammation without compromising host immune response against the sepsis-inducing pathogen or against secondary infections have not been found yet. The gene discussed is IL1B; the disease is Sepsis.